|
|
 |
ANHYDROUS DIBASIC CALCIUM PHOSPHATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$798.00 |
|
|
 |
ANHYDROUS LACTOSE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AKYNZEO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ASCORBIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|